The non-NMDA receptor antagonist NBQX does not affect rats performance in the object recognition task

Pharmacological Research

Volumn 45, Issue 1, 2002, Pages 43-46

  Pitsikas, Nikolaos ^a   Rigamonti, Antonello E ^a   Cella, Silvano G ^a   Muller, Eugenio E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

AMPA receptor; NBQX; Object recognition

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; ATAXIA; CONTROLLED STUDY; DRUG EFFECT; LEARNING; LOCOMOTION; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY; TASK PERFORMANCE;

EID: 0036446960     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2001.0898     Document Type: Article

References (29)

1. Curtis DR, Phillis JW, Watkins JC. Chemical excitation of spinal neurones. Nature 1959; 183: 610-2.
2. Cotman CW, Monaghan DT, Ottersen OP, Storm-Matthisen J. Anatomical organisation of excitatory amino acid receptors and their pathways. Trends Neurosci 1987; 10: 273-80.
3. Choi DW. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev 1990; 2: 105-47.
4. Lees GJ. Therapeutic potential of AMPA receptor ligands in neurological disorders. CNS Drugs 1996; 5: 51-74.
5. Gill R, Nordholm L, Lodge D. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischemia model. Brain Res 1992; 580: 35-43.
6. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honorè T. 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline(NBQX): A neuroprotectant for cerebral ischemia. Science 1990; 247: 571-4.
7. Young D, Dragunow M. MK-801 and NBQX prevent electrically induced status epilepticus. Neuroreport 1994; 5: 81-3.
8. Turski L, Jacobsen P, Honorè T, Stephens DN. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. J Pharmacol Exp Ther 1992; 260: 742-7.
9. Von Euler M, Seiger A, Holmberg L, Sundstrom E. NBQX, a competitive nonNMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia. Exp Neurol 1994; 129: 163-8.
10. Wrathall JR, Choiniere D, Teng YD. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J Neurosci 1994; 14: 6598-607.
11. Filliat P, Pernot-Marino I, Baubichon D, Lallement G. Behavioral effects of NBQX, a competitive antagonist of the AMPA receptors. Pharmacol Biochem Behav 1998; 59: 1087-92.
12. Flood JF, Baker ML, Davis GL. Modulation of memory processing by glutamic acid receptor agonists and antagonists. Brain Res 1990; 521: 197-202.
13. Steele RJ, Stewart MG. Involvement of AMPA receptors in maintenance of memory for a passive avoidance task in day-old domestic chicks (Gallus domesticus). Eur J Neurosci 1995; 7: 1297-304.
14. Zivkovic I, Thompson DM, Bertolino M, Uzunov D, Di Bella M, Costa E, Guidotti A. 7-chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): A benzothiadiazine derivative that enhances cognition by attenuating DL-α-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization. J Pharmacol Exp Ther 1995; 272: 300-9.
15. Danysz W, Zajaczkowski W, Parsons CG. Modulation of learning processes by ionotropic glutamate receptor ligands. Behav Pharmacol 1995; 6: 455-74.
16. Parada J, Czuczwar SJ, Turski WA. NBQX does not affect learning and memory tasks in mice: A comparison with D-CPPene and ifenprodil. Cogn Brain Res 1992; 1: 67-71.
17. 3H]kainate binding. Eur J Pharmacol 1993; 246: 195-204.
18. Parsons CG, Cruner R, Rozental J. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methylendioxyl-5H-2,3-benzodiazepine (GYKI 52466). Neuropharmacology 1994; 33: 589-604.
19. Suzdak PD, Sheardown MJ, Honorè T. Characterization of the metabotropic glutamate receptor in mouse cerebellar granule cells: Lack of effect of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX). Eur J Pharmacol 1993; 245: 215-20.
20. Ennaceur A, Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data. Behav Brain Res 1988; 31: 47-59.
21. Bartolini L, Casamenti F, Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav 1996; 53: 277-83.
22. Gill R. The pharmacology of (amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischemia. Cerebrovasc Brain Metab Rev 1994; 6: 225-56.
23. Chapman AG, Meldrum BS. Excitatory amino acid antagonism and epilepsy. Excitatory Amino Acids 1993; 21: 106-10.
24. Stephens DN, Cole BJ. AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks. Psychopharmacology 1996; 126: 249-59.
25. Bisaga A, Krzascik P, Palejko W, Jankowska E, Kostowski W, Danysz W. Effect of glutamate antagonists on NMDA-and ampa-induced convulsant effects in mice and rats. Eur J Pharmacol 1993; 242: 213-20.
26. Smith SE, Durmuller N, Meldrum BS. The non-N-methyl-D-aspartate receptor antagonists, GYKI-52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur J Pharmacol 1991; 201: 179-83.
27. Bliss TVP, Collingridge GL. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 1993; 361: 31-9.
28. Kapus G, Szekely JI, Durand J, Ruiz A, Tarnawa I. AMPA receptor antagonists, GYKI 52466 and NBQX do not block the induction of long-term potentiation at therapeutic relevant concentrations. Brain Res Bull 2000; 52: 511-7.
29. Sato K, Morimoto K, Yamada N, Kuroda S, Hayabara T. NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo. Brain Res 1995; 683: 279-82.